Uncovering a novel DNA repair-related radiosensitivity model for evaluation of radiotherapy susceptibility in uterine corpus endometrial cancer

Uncovering a novel DNA repair-related radiosensitivity model for evaluation of radiotherapy susceptibility in uterine corpus endometrial cancer

Background: Uterine corpus endometrial cancer (UCEC) exhibit heterogeneity in their DNA repair capacity, which can impact their response to radiotherapy. Our study aimed to identify potential DNA repair-related biomarkers for predicting radiation response in UCEC. Methods: We conducted a thorough an...

Full description

Bibliographic Details
Main Authors:	Hainan Yang, Yanru Qiu, Junjun Chen, Jinzhi Lai
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Heliyon
Subjects:	Uterine corpus endometrial cancer Radiotherapy Radiosensitivity DNA repair-related genes PD-L1
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402405432X

Similar Items

Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma
by: Qi Zhang, et al.
Published: (2024-02-01)

DEPDC1 is up-regulated in uterine corpus endometrial cancer
by: YANG Tingting, HUANG Jie, GUO Jianxin, HAN Jian
Published: (2023-09-01)

CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma
by: Shen Xue, et al.
Published: (2023-02-01)

FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma
by: Zhe Wang, et al.
Published: (2023-02-01)

Spectrum of Uterine corpus lesions in hysterectomy specimens
by: Sharadrutha A1 , Janaki M2
Published: (2017-08-01)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
by: Kang He, et al.
Published: (2023-01-01)

Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients
by: Qin Liu, et al.
Published: (2022-11-01)

Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity
by: Zhiru Gao, et al.
Published: (2023-05-01)

Comprehensive Analysis of Prognosis and Immune Landscapes Based on Lipid-Metabolism- and Ferroptosis-Associated Signature in Uterine Corpus Endometrial Carcinoma
by: Pusheng Yang, et al.
Published: (2023-02-01)

Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma
by: Yun Chen
Published: (2022-07-01)

Identification of a novel cuproptosis-associated lncRNA model that can improve prognosis prediction in uterine corpus endometrial carcinoma
by: Bohan Li, et al.
Published: (2023-12-01)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
by: Yan-Bin Jin, et al.
Published: (2023-07-01)

Depleted-MLH1 Expression Predicts Prognosis and Immunotherapeutic Efficacy in Uterine Corpus Endometrial Cancer: An In Silico Approach
by: Tesfaye Wolde, et al.
Published: (2024-02-01)

Identification of an endoplasmic reticulum stress-related gene signature to predict prognosis and potential drugs of uterine corpus endometrial cancer
by: Pei Zhou, et al.
Published: (2023-01-01)

Comprehensive Analysis of the Expression and Prognosis for MCM4 in Uterine Corpus Endometrial Carcinoma
by: Li-Peng Pei, et al.
Published: (2022-06-01)

RPP40 is a prognostic biomarker and correlated with tumor microenvironment in uterine corpus endometrial carcinoma
by: Jianming Tang, et al.
Published: (2022-08-01)

Comprehensive landscape of the functions and prognostic value of RNA binding proteins in uterine corpus endometrial carcinoma
by: Yong Yao, et al.
Published: (2022-10-01)

Identification of an integrated kinase-related prognostic gene signature associated with tumor immune microenvironment in human uterine corpus endometrial carcinoma
by: Sitian Wei, et al.
Published: (2022-09-01)

Construction of the novel immune risk scoring system related to CD8+ T cells in uterine corpus endometrial carcinoma
by: Ganghua Zhang, et al.
Published: (2023-06-01)

A review on lymphocyte radiosensitivity and its impact on radiotherapy
by: Harald Paganetti, et al.
Published: (2023-08-01)

Discovering common pathogenetic processes between polycystic ovary syndrome and uterine corpus endometrial carcinoma by bioinformatics and experimental approach
by: Mingming Wang, et al.
Published: (2024-02-01)

Is HOXA5 a Novel Prognostic Biomarker for Uterine Corpus Endometrioid Adenocarcinoma?
by: Changho Song, et al.
Published: (2023-09-01)

Endoplasmic reticulum stress related IncRNA signature predicts the prognosis and immune response evaluation of uterine corpus endometrial carcinoma
by: Jun Chen, et al.
Published: (2023-01-01)

Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma
by: Tao Wang, et al.
Published: (2023-01-01)

Uterin lipoma, leiyomyoma ve endometrial polip birlikteliği
by: Nilgün SÖĞÜTÇÜ, et al.
Published: (2019-09-01)

The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment Decisions
by: Matthias Alexa, et al.
Published: (2021-03-01)

Deciphering comprehensive features of tumor microenvironment controlled by chromatin regulators to predict prognosis and guide therapies in uterine corpus endometrial carcinoma
by: Qihui Wu, et al.
Published: (2023-03-01)

Biomimetic radiosensitizers unlock radiogenetics for local interstitial radiotherapy to activate systematic immune responses and resist tumor metastasis
by: Jiajia Zhang, et al.
Published: (2022-03-01)

Targeting the organelle for radiosensitization in cancer radiotherapy
by: Xiaoyan Sun, et al.
Published: (2024-04-01)

Albumin-Modified Gold Nanoparticles as Novel Radiosensitizers for Enhancing Lung Cancer Radiotherapy
by: Chen Y, et al.
Published: (2023-04-01)

Retrospective examination of endometrial sampling results in women with abnormal uterine bleeding
by: Reyhan Aydın Doğan, et al.
Published: (2023-04-01)

Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme
by: Jinyeong Choi, et al.
Published: (2020-09-01)

Effect of Gold Nanoparticle Radiosensitization on DNA Damage Using a Quartz Tuning Fork Sensor
by: Nadyah Alanazi, et al.
Published: (2023-10-01)

Combination of Electrochemotherapy with Radiotherapy: A Comprehensive, Systematic, PRISMA-Compliant Review of Efficacy and Potential Radiosensitizing Effects in Tumor Control
by: Martina Ferioli, et al.
Published: (2023-11-01)

Risk-Tailoring Radiotherapy for Endometrial Cancer: A Narrative Review
by: Kristin Hsieh, et al.
Published: (2024-03-01)

Abnormal Uterine Bleeding- evaluation by Endometrial Aspiration
by: Pratibha Singh
Published: (2018-01-01)

Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients
by: Nora Tong, et al.
Published: (2023-04-01)

New Aspects of Sarcomas of Uterine Corpus—A Brief Narrative Review
by: Stoyan Kostov, et al.
Published: (2021-11-01)

Histopathological Study of Endometrial Sampling in Abnormal Uterine Bleeding
by: Dr. Shraddha J Patel, et al.
Published: (2023-06-01)

Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol
by: Dominika Komorowska, et al.
Published: (2022-09-01)